Alzheimer’s disease and dementia present profound challenges in cognitive and functional decline among the elderly. While not curative, antipsychotic medications are sometimes used to manage behavioral symptoms like agitation, aggression, and hallucinations that can arise in these conditions. However, their use in dementia care is controversial due to potential side effects, including increased risk of stroke, sedation, and accelerated cognitive decline. Non-pharmacological approaches such as structured routines, cognitive stimulation, and environmental modifications are preferred whenever possible. Careful consideration by healthcare providers is essential, weighing the risks and benefits to ensure the highest quality of life for patients while minimizing adverse effects. Ongoing research aims to refine treatment strategies, emphasizing personalized care approaches tailored to the unique needs and responses of individuals with Alzheimer’s disease and other forms of dementia.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China